B O O K - American College of Rheumatology

Session Overview:
Ultrasound and magnetic resonance imaging are sensitive
imaging tools to define the degree of arthritis in patients with
juvenile idiopathic arthritis. Data from adult patients with
rheumatoid arthritis point to the importance of ultrasound and
MRI for early diagnosis and therapeutic monitoring. In JIA both
ultrasound and MRI criteria for arthritis urgently need to be
defined and implemented in the remission criteria of JIA since
the disease tends to progress silently in a group of patients
leading to joint destruction and early arthrotic changes.
Upon completion of this session, participants should be able to:
• discuss the advantages/disadvantages of ultrasound and MRI
for the detection of arthritis in adults with RA and possible
application in children with JIA
• identify the risk of developing silent arthritis in patients with
RA and children with JIA
• articulate the benefits of monitoring the treatment by
ultrasound/MRI in patients with RA and possible application in
children with JIA
• discuss the possible application of ultrasound/MRI for early
diagnosis of JIA and treatment monitoring
A314
Interstitial Lung Diseases in the Rheumatic Diseases
Moderators: Paul F. Dellaripa, MD; Brigham and Women’s
Hospital; Boston, MA
Kristin B. Highland, MD; Medical University of South Carolina;
Charleston, SC
1:00 PM
Update on OMERACT in the Rheumatic Diseases
Kristine Phillips, MD, PhD; University of Michigan; Ann Arbor, MI
Shikha Mittoo, MD, MHS; Univeristy of Manitoba; Winnipeg, MB,
Canada
Lesley Ann Saketkoo, MD, MPH; LSU Health Science Center;
Highland Beach, FL
1:20 PM
RA and ILD: Results of Open Label Trials
Eric L. Matteson, MD; Mayo Clinic; Rochester, MN
1:40 PM
Antisynthetase Syndrome and ILD: Environmental Factors
Kristin B. Highland, MD; Medical University of South Carolina;
Charleston, SC
Session Overview:
Interstitial lung disease is a feared manifestation of a variety
of rheumatic diseases. While studies and a consortium exist
for ILD/scleroderma, our understanding of the natural history,
pathophysiology and treatment of ILD in other rheumatic
disorders such as RA and dermatomyositis is poorly understood
and no such consortium exists. A study group provides a
forum for collaboration for clinical investigators to enhance
our knowledge of and treatment of these life threatening
manifestations of rheumatic diseases. This will be our third year
and already our collaboration has netted the development of an
OMERACT project and one prospective study in ILD. The group
has become truly multidisciplinary and growing in size and scope
and we would like to maintain that momentum.
Upon completion of this session, participants should be able to:
• identify emerging epidemiologic and genetic mechanisms in
ILD associated with myositis and antisynthetase syndrome
• describe progress in the area of outcomes research regarding
OMERACT in ILD and the rheumatic diseases
B314
JAW (Juvenile Arthritis Workgroup)
Moderators: Randy Q. Cron, MD, PhD; Children’s Hospital of
Alabama; Birmingham, AL
Marinka Twilt, MD, PhD; Erasmus MC Sophia Children’s Hospital/
Leiden University Medical Center; Rotterdam, Netherlands
1:00 PM
Prevalence and Outcome of TMJ Arthritis in JIA Subtypes
Rotraud K. Saurenmann, MD; University Children’s Hospital;
Zurich, Switzerland
1:15 PM
Imaging Modalities for Detecting TMJ Arthritis
Tore Larheim, DDS, PhD; University of Oslo; Oslo, Norway
1:30 PM
TMJ Arthritis and Intraarticular Corticosteroid Injections
Randy Q. Cron, MD, PhD; Children’s Hospital of Alabama;
Birmingham, AL
1:45 PM
Early Orthodontic Treatment of TMJ Arthritis
Volkan Ozkan, MD; University of Frankfurt; Kronberg, Germany
Session Overview:
Temporomandibular joint arthritis occurs in up to 87 percent of
the children with juvenile idiopathic arthritis, many cases are
asymptomatic. Late recognition leads to condylar destruction
resulting in micro-/retrognathia, facial asymmetry and early
arthritic changes. Several studies have tried to define the
most sensitive clinical and imaging screening tool for early
detection of TMJA, but the optimal screening tool and timing
remain unclear. Recently intraarticular corticosteroids and early
application of orthodontic devices have shown promising results.
However, optimal therapy for prevention of short and long term
consequences of TMJA in JIA remains unanswered.
Upon completion of this session, participants should be able to:
• identify the risk of developing TMJ arthritis in patients with JIA
• discuss the advantages/disadvantages of clinical examination
and imaging modalities to detect TMJ arthritis in children with
JIA
• articulate the benefits of intraarticular corticosteroid injection
for the treatment of TMJ arthritis in patients with JIA
• articulate the benefits of early orthodontic treatment
A311
Musculoskeletal Ultrasound
Moderator: Gurjit S. Kaeley, MBBS; University of Florida College
of Medicine; Ponte Vedra Beach, FL
1:00 PM
Use of Ultrasound in Fibrosing Diseases
Eugene Y. Kissin, MD; Boston University; Boston, MA
wednesday
2010 Program Book 109